@article{JTD1145,
author = {Feng Xie},
title = {Model-based economic evaluation for medical decision making: learn from the past and prepare for the future},
journal = {Journal of Thoracic Disease},
volume = {5},
number = {3},
year = {2013},
keywords = {},
abstract = {In July 2012 issue of Annals of Cardiothoracic Surgery, Gada and colleagues (1) presented an economic evaluation for transapical aortic valve implantation (TAVI) in high risk patients with aortic stenosis. A Markov model was developed to compare mortality, costs and quality-adjusted life years (QALYs) of TAVI with aortic valve replacement (AVR) and medical management from a payer’s perspective over a life time horizon. In the reference case, the incremental cost effectiveness ratios (ICERs) were \$44,384/QALY for TAVI and \$42,637/QALY for AVR when compared with the medical management, while TAVI was dominated by AVR (i.e. TAVI gained fewer QALYs at higher costs). The ICERs were sensitive to post-surgery mortality, health utilities, and the cost of TAVI.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/1145}
}